App-Quantinova.ai

Performance of Age-Adjusted D-Dimer Cut-off Values to Rule Out Venous Thromboembolism in Patients with Non-High Pre-Test Probability

Yann-Erick Claessens - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Antibodies to Human Factor XII with Antithrombotic Properties

Adam E. Gailani - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

DE-074

Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)

Ilaria Terrinoni - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Spinal Artery Thrombosis: An Unrecognized Severe Complication in Thalassemia and Sickle Disorders

Erika Poggiali - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Methylprednisolone

Risk of Venous Thrombosis Associated with White Cell Count On Peripheral Blood and Its Interrelationship with Other Environmental Risk Factors

Willem M. Lijfering - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Clinical Predictors of Confirmed Venous Thromboembolism in Patients with a Suspected Recurrent Venous Thromboembolism: A Retrospective Study of the Reverse I Cohort

Melanie Tan - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

TMEM16F Ion Channel Regulates Calcium-Dependent PS Exposure, Hemostasis, and Thrombosis

Huanghe Yang - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Phosphatidylserine

Miniaturized T2MR Magnetic Resonance System for Analysis of Hemostasis and Detection of Impaired and Prothrombotic Blood Disorders

Tatiana Lebedeva - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

Hemostatic Solution

The Co-Influence of VWD Type 2B and Type 2M Mutations and Platelet GPIb? On the Susceptibility of VWF to ADAMTS13 Under Shear Stress

Jingyu Zhang - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

High Mortality After Venous Thromboembolism: A Population-Based Cohort Study

Valerie Patenaude - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Temporal Incidence Trends of Pediatric Venous Thromboembolism: A Population-Based Cohort Study

Susan R. Kahn - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Postpartum Venous Thromboembolic Events Among Carriers of Factor V Leiden and/or Prothrombin Gene Variant: A Cohort Study and Updated Systematic Review. Is Prophylaxis Really Required?

Gregoire Le Gal - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Protein C

Catheter Related Thrombosis in Breast Cancer Patients: Risk Factors and Prognostic Implications

Patricia Cornejo - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

International Good Clinical Practices Guidelines (GCPG) for Antithrombotics in CANCER Patients

Debourdeau Philippe - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Heparin

The Effect of Fresh Frozen Plasma On the Incidence of Venous Thromboembolism and Haemorrhages in Children with Acute Lymphoblastic Leukaemia

Eva Stokhuijzen - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Dexamethasone

A Role of Platelet Activation in Lacunar Stroke?

Nadine Ajzenberg - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Albyl-E

Pharmacokinetics-Based Modification of Intravenous Pegylated Asparaginase Dosing in the Context of a Pediatric-inspired Protocol in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Dan Douer - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hydrocortisone

Host Genomic Variants and Risk of Infections During Induction Treatment in Childhood Acute Lymphoblastic Leukemia

Agata Wesolowska - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methotrexate

Host Genetics and Risk of Cardiovascular Disease in a Prospective Cohort of Adult Non-Hodgkin Lymphoma Survivors

Thomas M Habermann - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Very Low to Low Doses of Continuous Azacitidine in Combination with Standard Doses of Lenalidomide and Low-Dose Dexamethasone (Rd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Interim Results of a Phase I/II Study

Shahper N Khan - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Dexamethasone

Filters

7277 Abstracts